☆ 4.7 Article

Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination

SCIENCE IMMUNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination

Katharina Roltgen et al.

Summary: During the SARS-CoV-2 pandemic, different vaccines have been used globally. This study compares the antibodies generated by mRNA vaccines, infection, and other types of vaccines. It shows that mRNA vaccines result in a better antibody breadth against viral variants compared to infection. Infection leads to variant-specific antibodies, while mRNA vaccination imprints responses towards the original virus strain. mRNA vaccines also stimulate robust germinal centers in lymph nodes, enhancing the immune response.

CELL (2022)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans

Philip A. Mudd et al.

Summary: SARS-CoV-2 mRNA vaccines induce potent immune responses, including antibodies and CD4(+) T cell responses. Research has found that vaccine-induced follicular helper CD4(+) T cell responses play a key role in establishing long-term immunity.

CELL (2022)

Add to Collection

Article Microbiology

Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates

Tomer Zohar et al.

Summary: Through studying a nonhuman primate-challenge model, we found that immune protection against RSV infection is associated with antibody levels, neutralization, complement activity, and Fc-mediated effector mechanisms. These findings provide important insights for the development of future vaccines.

CELL HOST & MICROBE (2022)

Add to Collection

Article Immunology

Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines

Vivek Naranbhai et al.

Summary: Understanding the immunogenicity and effectiveness of SARS-CoV-2 vaccines is crucial. This study compared the immunogenicity and effectiveness of mRNA-1273, BNT-162b2, and Ad26.COV2.S in healthy adults. The results showed that mRNA vaccines and convalescent individuals had comparable antibody and neutralization titers, while Ad26.COV2.S had lower antibody concentrations. mRNA1273 and BNT162b2 induced higher T-cell responses. Prior infection was associated with high antibody concentrations and neutralization even after a single dose. Meta-analysis showed differences in effectiveness against infection, hospitalization, and death, with mRNA1273 being the most effective.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Multidisciplinary Sciences

Germinal centre-driven maturation of B cell response to mRNA vaccination

Wooseob Kim et al.

Summary: SARS-CoV-2 mRNA vaccination induces a persistent germinal center reaction in humans, resulting in affinity-matured long-term antibody responses that potently neutralize the virus.

NATURE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern

Paul R. Wratil et al.

Summary: This study reports on the dynamics of neutralizing antibodies in individuals convalescing from coronavirus disease 2019 or who are vaccine-naive and subsequently vaccinated. The findings suggest that infection-plus-vaccination-induced hybrid immunity or triple immunization can induce high-quality antibodies with superior neutralization capacity against variants of concern, including omicron.

NATURE MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost

Frauke Muecksch et al.

Summary: Receiving three doses of an mRNA vaccine can provide protection against the Omicron variant and induce the production of more potent and broader antibodies. This is due to the expansion and evolution of memory B cell clones, particularly the newly emerging clones that target more conserved regions.

NATURE (2022)

Add to Collection

Article Cell Biology

mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions

Paulina Kaplonek et al.

Summary: The successful development of COVID-19 vaccines has led to reduced morbidity and mortality. However, the emergence of viral variants has affected the efficacy of the vaccines, showing differences between two approved mRNA platforms, BNT162b2 and mRNA-1273. Understanding the differences in immune responses induced by these vaccines is important for determining their protective immunity.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates

Daniel Y. Zhu et al.

Summary: This study examines the role of neutralizing antibodies, Fc effector function, and T-cell immunity against SARS-CoV-2 infection. The results indicate that neutralizing antibodies and Fc receptor binding titers are linked to prevention of transmission, while Fc receptor binding/function and T cells are associated with antiviral control. This highlights the importance of Fc effector function as a correlate of immunity in halting and controlling SARS-CoV-2 and emerging variants.

PLOS BIOLOGY (2022)

Add to Collection

Article Infectious Diseases

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

Oliver J. Watson et al.

Summary: A study quantified the global impact of the first year of COVID-19 vaccination programs, finding that the vaccination has substantially altered the course of the pandemic, saving tens of millions of lives globally. However, inadequate access to vaccines in low-income countries has limited the impact, reinforcing the need for global vaccine equity and coverage.

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Article Medicine, General & Internal

Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2

Emanuel Vogel et al.

Summary: This study compared the dynamics of humoral and cellular immune responses up to 180 days after homologous or heterologous vaccination. The results showed that antibody responses significantly waned after vaccination, and heterologous vaccination resulted in stronger neutralization of SARS-CoV-2 and longer-lasting humoral immunity. All vaccination regimens induced stable, polyfunctional T-cell responses.

EBIOMEDICINE (2022)

Add to Collection

Article Infectious Diseases

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

Oliver J. Watson et al.

Summary: The study estimated that COVID-19 vaccination has prevented millions of deaths globally between December 8, 2020, and December 8, 2021. Achieving the vaccination coverage targets set by COVAX and WHO could have prevented even more deaths. However, limited access to vaccines in low-income countries has hindered the impact, highlighting the importance of global vaccine equity.

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Article Infectious Diseases

Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2

Dennis Lapuente et al.

Summary: The novel flow cytometric assay allows sensitive and quantitative detection of SARS-CoV-2-specific antibodies, which can be easily adopted in different laboratories without relying on external supply of assay kits.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)

Add to Collection

Letter Medicine, General & Internal

Serum IgG4 level predicts COVID-19 related mortality

Emanuel Della-Torre et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)

Add to Collection

Article Infectious Diseases

Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021

Margaux M. Mesle et al.

Summary: Between December 2019 and November 2021, COVID-19 vaccination in 33 countries in the World Health Organization European Region saved approximately 51% of expected deaths in the population aged 60 years and older. The impact of vaccination varied by country, with the largest effect seen in countries where implementation was carried out early.

EUROSURVEILLANCE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Maturation and persistence of the anti-SARS-CoV-2 memory B cell response

Aurelien Sokal et al.

Summary: Memory B cells play a crucial role in host defense against SARS-CoV-2, with distinct B cell clone responses to the virus contributing to long-lasting immune protection. The study also highlights the significance of somatic mutations in the variable region genes of memory B cells over time, indicating continued maturation and long-term immune memory post-infection.

CELL (2021)

Add to Collection

Article Medicine, General & Internal

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Alasdair P S Munro et al.

LANCET (2021)

Add to Collection

Article Multidisciplinary Sciences

Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination

Alice Cho et al.

Summary: Infection with SARS-CoV-2 leads to evolving B cell responses over at least a year, while vaccination with mRNA vaccines results in high plasma neutralizing activity against various variants. Memory B cells from vaccinated individuals show increased neutralizing activity between prime and boost, but do not exhibit further expansion in potency or breadth.

NATURE (2021)

Add to Collection

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Cell Biology

Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern

Inbal Farkash et al.

Summary: mRNA-based COVID-19 vaccines induce strong anti-SARS-CoV-2 antibody responses with unique and dynamic Fc compositions. The vaccine-induced antibodies exhibit differences in Fab and Fc-mediated functions between age groups and natural infection-generated antibodies. These findings suggest heterogeneity in Fc responses to SARS-CoV-2 infection and vaccination may support long-lasting protection differently.

CELL REPORTS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants

Laith J. Abu-Raddad et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

Stefania Dispinseri et al.

Summary: The study reveals that antibody responses to SARS-CoV-2 spike protein play a significant role in neutralization and protection against severe COVID-19, unaffected by heterologous boosting or common cold immunity, and can last for up to 8 months.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Medicine, General & Internal

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

Jamie Lopez Bernal et al.

Summary: This study estimated the real-world effectiveness of Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed COVID-19 symptoms, hospital admissions, and deaths. The vaccines showed significant reduction in symptomatic COVID-19 among older adults and further protection against severe disease. Both vaccines demonstrated similar effects and protection was maintained for over 6 weeks.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Integrated analysis of multimodal single-cell data

Yuhan Hao et al.

Summary: The study introduces a weighted-nearest neighbor analysis framework to learn the relative utility of each data type in each cell, enabling integrative analysis of multiple modalities. Applied to a CITE-seq dataset, the method constructs a multimodal reference atlas of the circulating immune system and successfully identifies and validates previously unreported lymphoid subpopulations.

CELL (2021)

Add to Collection

Letter Infectious Diseases

Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2

Matthias Tenbusch et al.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Article Multidisciplinary Sciences

Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy

Rachel Yamin et al.

Summary: Monoclonal antibodies with optimized Fc domains show superior potency in preventing and treating COVID-19 in animal disease models, reducing the dose required for protection against SARS-CoV-2 challenge and for treating pre-infected animals. Selective engagement of activating Fc receptors results in improved efficacy, highlighting the importance of Fc receptor pathways in driving antibody-mediated antiviral immunity. These findings have implications for the development of Fc-engineered monoclonal antibodies with optimal Fc-effector function against COVID-19.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses

Jackson S. Turner et al.

Summary: SARS-CoV-2 mRNA vaccines induce a persistent germinal centre B cell response in humans, leading to the generation of robust humoral immunity, especially more significant in individuals previously infected with the virus.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients

Andrew D. Moura et al.

Summary: This study assessed antibody levels, avidity, and subclasses of IgG against RBD protein in symptomatic COVID-19 patients in Brazil. Results showed that severe COVID-19 patients had higher antibody levels, most patients had low antibody avidity, and some life-threatening patients showed increased IgG4 levels in the first week of symptoms onset. The findings highlight the importance of IgG antibody avidity and IgG4 detection as a potential tool in monitoring hospitalized patients with severe disease.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Immunology

The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity

Sonia Tejedor Vaquero et al.

Summary: mRNA-1273 vaccine induces cross-variant antibody responses in individuals with or without pre-existing immunity against SARS-CoV-2, with higher titers of IgG1 and IgA in those with prior infection history. COVID-19 recovered subjects do not show a recall antibody response upon the second vaccine dose, but still maintain higher levels of certain antibodies compared to fully vaccinated naive individuals.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Cell Biology

Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity

Jennifer L. Yates et al.

Summary: The severity of COVID-19 is associated with elevated levels of SARS-CoV-2-specific antibodies in severe cases, with spike-specific IgG subclass utilization potentially contributing to disease severity through potent Fc-mediated effector functions. These findings may have significant implications for SARS-CoV-2 vaccine design and convalescent plasma therapy.

CELL REPORTS MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Add to Collection

Article Biochemical Research Methods

A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation

Stephanie Fischinger et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2019)

Add to Collection

Review Immunology

Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine

Carolyn M. Boudreau et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Allergy

High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers

T. Boonpiyathad et al.

ALLERGY (2017)

Add to Collection

Article Cell Biology

Human IgG2-and IgG4-expressing memory B cells display enhanced molecular and phenotypic signs of maturity and accumulate with age

Britt G. de Jong et al.

IMMUNOLOGY AND CELL BIOLOGY (2017)

Add to Collection

Article Virology

Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies

Silvie Van den Hoecke et al.

JOURNAL OF VIROLOGY (2017)

Add to Collection

Article Biochemical Research Methods

Simultaneous epitope and transcriptome measurement in single cells

Marlon Stoeckius et al.

NATURE METHODS (2017)

Add to Collection

Article Biology

Lineage tracing of human B cells reveals the in vivo landscape of human antibody class switching

Felix Horns et al.

ELIFE (2016)

Add to Collection

Review Immunology

Mouse and human FcR effector functions

Pierre Bruhns et al.

IMMUNOLOGICAL REVIEWS (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

David J. DiLillo et al.

NATURE MEDICINE (2014)

Add to Collection

Article Cell Biology

Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines

Amy W. Chung et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

Add to Collection

Review Immunology

IgG subclasses and allotypes: from structure to effector functions

Gestur Vidarsson et al.

FRONTIERS IN IMMUNOLOGY (2014)

Add to Collection

Article Biochemical Research Methods

A novel assay for detecting virus-specific antibodies triggering activation of Feγ receptors

Eugenia Corrales-Aguilar et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2013)

Add to Collection

Article Medicine, General & Internal

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

Barton F. Haynes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Add to Collection

Article Biochemical Research Methods

A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples

Margaret E. Ackerman et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2011)

Add to Collection

Article Multidisciplinary Sciences

A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins

Davide Corti et al.

SCIENCE (2011)

Add to Collection

Article Medicine, General & Internal

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

Supachai Rerks-Ngarm et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Add to Collection

Review Immunology

Mechanism and regulation of class switch recombination

Janet Stavnezer et al.

ANNUAL REVIEW OF IMMUNOLOGY (2008)

Add to Collection

Article Biochemical Research Methods

Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning

Thomas Tiller et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2008)

Add to Collection

Article Oncology

Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells

John O. Richards et al.

MOLECULAR CANCER THERAPEUTICS (2008)

Add to Collection

Article Biochemistry & Molecular Biology

IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis

Xavier Brochet et al.

NUCLEIC ACIDS RESEARCH (2008)

Add to Collection

Review Allergy

Mechanisms of allergen-specific immunotherapy

CA Akdis et al.

ALLERGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.